| scholarly article | Q13442814 |
| P50 | author | Ramon Brugada | Q1546186 |
| Josep Brugada | Q1706299 | ||
| Pedro Brugada | Q1882575 | ||
| Lucio Capulzini | Q91640123 | ||
| P2860 | cites work | Arrhythmogenic right ventricular cardiomyopathy/dysplasia | Q21202959 |
| Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2) | Q24290749 | ||
| Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias | Q24298971 | ||
| Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium: are they different diseases? | Q74567055 | ||
| Identification and ablation of macroreentrant ventricular tachycardia with the CARTO electroanatomical mapping system | Q74789908 | ||
| Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome | Q78408636 | ||
| Spontaneous electrocardiographic fluctuations in Brugada syndrome: does it matter? | Q79136574 | ||
| Gender differences in Brugada syndrome | Q79740447 | ||
| Catheter mapping and ablation of right ventricular outflow tract ventricular tachycardia | Q79889650 | ||
| Sex hormone and gender difference--role of testosterone on male predominance in Brugada syndrome | Q80062685 | ||
| A prospective study on spontaneous fluctuations between diagnostic and non-diagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification | Q80213154 | ||
| Outcomes in athletes with marked ECG repolarization abnormalities | Q80471116 | ||
| Three-dimensional electroanatomical voltage mapping and histologic evaluation of myocardial substrate in right ventricular outflow tract tachycardia | Q80718080 | ||
| The "short-coupled" variant of right ventricular outflow ventricular tachycardia: a not-so-benign form of benign ventricular tachycardia? | Q81063516 | ||
| Type I Brugada electrocardiogram pattern during the recovery phase of exercise testing | Q81183054 | ||
| [Ventricular tachycardia induced by exercise testing in a patient with Brugada syndrome] | Q81395198 | ||
| Number of electrocardiogram leads displaying the diagnostic coved-type pattern in Brugada syndrome: a diagnostic consensus criterion to be revised | Q83196263 | ||
| Role of genetic testing in arrhythmogenic right ventricular cardiomyopathy/dysplasia | Q84798495 | ||
| Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy | Q24299388 | ||
| Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy | Q24310389 | ||
| Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome | Q24655604 | ||
| Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene | Q24656100 | ||
| Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death | Q24675134 | ||
| The cardiac sodium channel: gating function and molecular pharmacology | Q28207195 | ||
| A genetic variants database for arrhythmogenic right ventricular dysplasia/cardiomyopathy | Q28250468 | ||
| Genetic basis and molecular mechanism for idiopathic ventricular fibrillation | Q28265902 | ||
| Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy | Q28288328 | ||
| Value of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutations | Q28291121 | ||
| Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study | Q30489889 | ||
| Clinical and molecular heterogeneity in the Brugada syndrome: a novel gene locus on chromosome 3. | Q33147352 | ||
| Natural history of Brugada syndrome: insights for risk stratification and management | Q33147491 | ||
| Determinants of Sudden Cardiac Death in Individuals With the Electrocardiographic Pattern of Brugada Syndrome and No Previous Cardiac Arrest | Q33150723 | ||
| Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. | Q33150735 | ||
| Hydroquinidine therapy in Brugada syndrome | Q33151389 | ||
| Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy | Q33151854 | ||
| Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more? | Q33152716 | ||
| Malignant entity of idiopathic ventricular fibrillation and polymorphic ventricular tachycardia initiated by premature extrasystoles originating from the right ventricular outflow tract | Q33153125 | ||
| Risk stratification of individuals with the Brugada electrocardiogram: a meta-analysis | Q33154041 | ||
| Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study | Q33154495 | ||
| Syncope due to Brugada syndrome in a young athlete | Q33154536 | ||
| Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome | Q33154721 | ||
| Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. | Q33175413 | ||
| Arrhythmogenic right ventricular dysplasia/cardiomyopathy: need for an international registry. Study Group on Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy of the Working Groups on Myocardial and Pericardial Disease and Arrhythmias of th | Q33867965 | ||
| Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation | Q33876613 | ||
| Ventricular tachycardia catheter ablation in arrhythmogenic right ventricular dysplasia: a 16-year experience | Q33934722 | ||
| Arrhythmogenic right ventricular dysplasia: MRI findings | Q34008205 | ||
| Cardiac abnormalities in familial palmoplantar keratosis | Q34048945 | ||
| Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. | Q34107541 | ||
| Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome | Q34232976 | ||
| Arrhythmogenic right ventricular cardiomyopathy: An update | Q34326219 | ||
| Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. | Q34385271 | ||
| Right ventricular cardiomyopathy and sudden death in young people | Q34687427 | ||
| Brugada syndrome | Q61608949 | ||
| Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia | Q68182850 | ||
| Pathologic evidence of extensive left ventricular involvement in arrhythmogenic right ventricular cardiomyopathy | Q68235954 | ||
| Adenosine-sensitive ventricular tachycardia: evidence suggesting cyclic AMP-mediated triggered activity | Q70143894 | ||
| Adenosine-sensitive ventricular tachycardia. Clinical characteristics and response to catheter ablation | Q70526601 | ||
| Successful radiofrequency catheter ablation for macroreentrant ventricular tachycardias in a patient with tetralogy of Fallot after corrective surgery | Q71567744 | ||
| Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study | Q73101304 | ||
| Triggering of sudden death from cardiac causes by vigorous exertion | Q73168557 | ||
| Clinical and electrophysiological differences between patients with arrhythmogenic right ventricular dysplasia and right ventricular outflow tract tachycardia | Q73343040 | ||
| Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome: clinical implication of eighty-seven-lead body surface potential mapping and its application to twelve-lead electrocardiograms | Q73788886 | ||
| Long-term survival in patients with repair of tetralogy of Fallot: 36-year follow-up of 490 survivors of the first year after surgical repair | Q73832146 | ||
| Idiopathic ventricular outflow tract tachycardia: where does it originate? | Q73957405 | ||
| Right ventricular arrhythmia: emergence of magnetic resonance imaging as an investigative tool | Q74108224 | ||
| Long-term follow-up of right ventricular monomorphic extrasystoles | Q74353576 | ||
| Right ventricular dysplasia: a report of 24 adult cases | Q34714742 | ||
| Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International S | Q34727600 | ||
| Gender differences in various types of idiopathic ventricular tachycardia | Q34760222 | ||
| Genetic control of sodium channel function | Q35090063 | ||
| The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5) | Q35097764 | ||
| Magnetic resonance and computed tomography imaging of arrhythmogenic right ventricular dysplasia | Q35788385 | ||
| Introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities-general considerations | Q36101154 | ||
| Ablation of idiopathic right ventricular outflow tract tachycardia: current perspectives | Q36247412 | ||
| Arrhythmogenic right ventricular cardiomyopathy/dysplasia: risk stratification and therapy | Q36426852 | ||
| Abnormal expression of cardiac neural crest cells in heart development: a different hypothesis for the etiopathogenesis of Brugada syndrome | Q36753059 | ||
| Protagonist: routine screening of all athletes prior to participation in competitive sports should be mandatory to prevent sudden cardiac death | Q36776271 | ||
| Catheter ablation for ventricular tachycardia | Q36833525 | ||
| Catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia. | Q37313974 | ||
| Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry | Q37357225 | ||
| Phenotypic overlap of cardiac sodium channelopathies: individual-specific or mutation-specific? | Q37428495 | ||
| Sodium channel mutations and arrhythmias | Q37450777 | ||
| Arrhythmias originating from the right ventricular outflow tract: how to distinguish "malignant" from "benign"? | Q37583243 | ||
| Assessment of right ventricular regional contraction and comparison with the left ventricle in normal humans: a cine magnetic resonance study with presaturation myocardial tagging | Q41336103 | ||
| Sustained ventricular tachycardia in adult patients late after repair of tetralogy of Fallot | Q41627079 | ||
| New-onset atrial fibrillation as first clinical manifestation of latent Brugada syndrome: prevalence and clinical significance | Q43288607 | ||
| Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? | Q43941621 | ||
| Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males | Q44172156 | ||
| Diagnostic accuracy of right ventriculography in arrhythmogenic right ventricular cardiomyopathy | Q44707032 | ||
| The prevalence of Brugada ECG in adult patients in a large university hospital in the western United States | Q46174920 | ||
| Safety of sports participation in patients with implantable cardioverter defibrillators: a survey of heart rhythm society members | Q46283895 | ||
| A mutation in the sodium channel is responsible for the association of long QT syndrome and familial atrial fibrillation | Q46311436 | ||
| Sudden unexplained death syndrome in Southeast Asia | Q46758152 | ||
| SCN5A mutation associated with cardiac conduction defect and atrial arrhythmias | Q48549245 | ||
| Prevalence and mortality of the Brugada-type electrocardiogram in one city in Japan. | Q50682172 | ||
| Catheter ablation of ventricular tachycardia after repair of congenital heart disease: electroanatomic identification of the critical right ventricular isthmus. | Q50876101 | ||
| Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia. | Q51442238 | ||
| Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: a role for genotyping in decision-making? | Q51547154 | ||
| Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. | Q51674425 | ||
| A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. | Q51772909 | ||
| Patients with scar-related right ventricular tachycardia: determinants of long-term outcome. | Q51822407 | ||
| Exercise-induced ECG changes in Brugada syndrome. | Q54458188 | ||
| Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. | Q55638651 | ||
| Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1 | Q55670706 | ||
| Long-Term Outcome in Patients Undergoing Surgical Repair of Tetralogy of Fallot | Q56987027 | ||
| Long-Term Efficacy of Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy | Q57736293 | ||
| Feasibility and Variability of Three Dimensional Echocardiography in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy | Q57736357 | ||
| Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging | Q57736500 | ||
| Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria | Q59286856 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | Spanish | Q1321 |
| English | Q1860 | ||
| P921 | main subject | heart disease | Q190805 |
| P304 | page(s) | 963-983 | |
| P577 | publication date | 2010-08-01 | |
| P1433 | published in | Revista Española de Cardiología | Q2467119 |
| P1476 | title | Arrhythmia and right heart disease: from genetic basis to clinical practice | |
| P478 | volume | 63 |
| Q90282403 | Arrhythmogenic mechanisms of obstructive sleep apnea in heart failure patients |
| Q34467730 | Delayed conduction and its implications in murine Scn5a(+/-) hearts: independent and interacting effects of genotype, age, and sex |
| Q28307856 | Genetics of sudden cardiac death syndromes |
| Q42173761 | Sudden cardiac death in young athletes |
| Q60595371 | TMEM43-S358L mutation enhances NF-κB-TGFβ signal cascade in arrhythmogenic right ventricular dysplasia/cardiomyopathy |
| Q33164606 | Treatment of anxiety and depression in a patient with brugada syndrome. |
Search more.